Avista Healthcare Partners, L.p. - Net Worth and Insider Trading

Avista Healthcare Partners, L.p. Net Worth

The estimated net worth of Avista Healthcare Partners, L.p. is at least $0 dollars as of 2024-06-06. Avista Healthcare Partners, L.p. is the 10% Owner of RVL Pharmaceuticals PLC and owns about 24,763,859 shares of RVL Pharmaceuticals PLC (RVLPQ) stock worth over $0. Details can be seen in Avista Healthcare Partners, L.p.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Avista Healthcare Partners, L.p. has not made any transactions after 2022-08-08 and currently still holds the listed stock(s).

Transaction Summary of Avista Healthcare Partners, L.p.

To

Avista Healthcare Partners, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Avista Healthcare Partners, L.p. owns 1 companies in total, including RVL Pharmaceuticals PLC (RVLPQ) .

Click here to see the complete history of Avista Healthcare Partners, L.p.’s form 4 insider trades.

Insider Ownership Summary of Avista Healthcare Partners, L.p.

Ticker Comapny Transaction Date Type of Owner
RVLPQ RVL Pharmaceuticals PLC 2022-08-08 10 percent owner

Avista Healthcare Partners, L.p. Latest Holdings Summary

Avista Healthcare Partners, L.p. currently owns a total of 1 stock. Avista Healthcare Partners, L.p. owns 24,763,859 shares of RVL Pharmaceuticals PLC (RVLPQ) as of August 8, 2022, with a value of $0.

Latest Holdings of Avista Healthcare Partners, L.p.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RVLPQ RVL Pharmaceuticals PLC 2022-08-08 24,763,859 0.00 0

Holding Weightings of Avista Healthcare Partners, L.p.


Avista Healthcare Partners, L.p. Form 4 Trading Tracker

According to the SEC Form 4 filings, Avista Healthcare Partners, L.p. has made a total of 1 transactions in RVL Pharmaceuticals PLC (RVLPQ) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in RVL Pharmaceuticals PLC is the acquisition of 8,000,000 shares on August 8, 2022, which cost Avista Healthcare Partners, L.p. around $12 Million.

Insider Trading History of Avista Healthcare Partners, L.p.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Avista Healthcare Partners, L.p. Trading Performance

GuruFocus tracks the stock performance after each of Avista Healthcare Partners, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Avista Healthcare Partners, L.p. is 3.14%. GuruFocus also compares Avista Healthcare Partners, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Avista Healthcare Partners, L.p. within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Avista Healthcare Partners, L.p.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Avista Healthcare Partners, L.p.

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 64.15 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 67.38 LIMIT LIMIT LIMIT LIMIT LIMIT

Avista Healthcare Partners, L.p. Ownership Network

Ownership Network List of Avista Healthcare Partners, L.p.

No Data

Ownership Network Relation of Avista Healthcare Partners, L.p.

Insider Network Chart

Avista Healthcare Partners, L.p. Owned Company Details

What does RVL Pharmaceuticals PLC do?

Who are the key executives at RVL Pharmaceuticals PLC?

Avista Healthcare Partners, L.p. is the 10 percent owner of RVL Pharmaceuticals PLC. Other key executives at RVL Pharmaceuticals PLC include 10 percent owner Foundation Harsaul , 10 percent owner Altchem Ltd , and director & 10 percent owner David F Burgstahler .

RVL Pharmaceuticals PLC (RVLPQ) Insider Trades Summary

Over the past 18 months, Avista Healthcare Partners, L.p. made no insider transaction in RVL Pharmaceuticals PLC (RVLPQ). Other recent insider transactions involving RVL Pharmaceuticals PLC (RVLPQ) include a net sale of 17,544,196 shares made by Foundation Harsaul , and a net sale of 17,544,196 shares made by Altchem Ltd .

In summary, during the past 3 months, insiders sold 0 shares of RVL Pharmaceuticals PLC (RVLPQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 35,088,392 shares of RVL Pharmaceuticals PLC (RVLPQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 35,088,392 shares.

RVL Pharmaceuticals PLC (RVLPQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

RVL Pharmaceuticals PLC Insider Transactions

No Available Data

Avista Healthcare Partners, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Avista Healthcare Partners, L.p.. You might contact Avista Healthcare Partners, L.p. via mailing address: 65 E. 55th Street, 18th Floor, New York Ny 10022.

Discussions on Avista Healthcare Partners, L.p.

No discussions yet.